The radiotherapy treatment comes from an electrical machine called a ‘Linear accelerator’ and is directed as a beam to the part of the body that needs to be treated. Treatment is given daily over a period of days or weeks and you may hear people call these treatments ‘fractions’. They are just a fraction of your treatment dose and plan.
Immunotherapy is a biological therapy and type of targeted treatment that boosts the patient’s natural defence, the immune system, and enables it to find and destroy cancer cells found in the body. At Rutherford Cancer Centres, we use several different types of immunotherapy in the treatment of cancer, in order to prevent cells growing and replicating or spreading around the body.
Chemotherapy at the Rutherford takes place in our modern therapy suites, consisting of up to ten treatment areas offering treatment for haematology/oncology patients requiring systemic anti-cancer therapy (SACT) and supportive care in an outpatient setting. The infusion therapy suites are available for patients undergoing treatment for breast, urology, upper and lower gastrointestinal cancers, and both malignant and non-malignant haematology disorders.
Professor Peter Barrett-Lee is a Consultant Clinical Oncologist, Professor of Oncology in the School of Medicine at Cardiff University and lead specialist in breast cancer and skin cancer at Velindre NHS Trust and the University of Wales.
Professor Peter Barrett-Lee was Medical Registrar at Mayday Hospital, Croydon and gained Membership of the Royal College of Physicians in 1985. He gained his Doctorate of Medicine Thesis in the laboratory of the Medical Breast unit at St George’s Hospital, London under the supervision of Professor R Charles Coombes. He trained for 5 years in both radiotherapy and medical oncology at the Royal Marsden Hospital and obtained the Fellowship of the Royal College of Radiologists. He then worked at the Meyerstein Institute of Clinical Oncology at UCL Hospitals London on several clinical trials of new hormones and chemotherapy that have now become standard treatments.
Find out more by visiting Professor Peter Barrett-Lees profile on: www.bupa.co.uk
Fellow Royal College of Radiologists
Fellow of Royal College of Physicians of London
Fellow of Royal College of Physicians of Edinburgh
Professor Peter Barrett-Lee does not hold a share or financial interest in the Rutherford Cancer Centres or another Proton Partners International company.
Professor Peter Barrett-Lee does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Proton Partners International company.
Professor Peter Barrett-Lee does hold a paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Proton Partners International.